Habitrol Lozenge
Product Images NDC 43598-987

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Habitrol (NDC 43598-987). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (2 mg Carton)

Habitrol Nicotine Polacrilex Lozenge 2 mg packaging label by Dr. Reddy's Laboratories Inc. The label highlights a mint flavor lozenge, with 72 lozenges per package divided into 3 bottles of 24 each. It also includes a drug facts panel with active ingredient, usage, warnings, directions, and ingredients information, emphasizing the product is a stop smoking aid.*

FDA Label Image

Container (2 mg Container)

Label for Habitrol Nicotine Polacrilex Lozenge 2 mg, a stop smoking aid. The product contains 24 lozenges, each with 2 mg nicotine. It is mint flavored and distributed by Dr. Reddy's Laboratories Inc. The label includes dosing directions and warnings. The NDC is 43598-986-24.*

FDA Label Image

Carton (4 mg Carton)

Packaging label for Habitrol Nicotine Polacrilex Lozenge Mint, 4 mg, an oral stop smoking aid lozenge by Dr. Reddy's Laboratories Inc. The box contains 72 lozenges (3 bottles of 24 lozenges each). The label highlights the mint flavor and includes usage instructions, warnings, and drug facts in a readable format with a bottle image displaying the product.*

FDA Label Image

Container (4 mg Container)

The label for Habitrol Nicotine Polacrilex Lozenge, 4 mg, a stop smoking aid in lozenge form. The label indicates 24 lozenges per container with mint flavor, distributed by Dr. Reddy's Laboratories Inc. It includes dosage instructions for up to 12 weeks and cautions about tamper-evident packaging and keeping out of reach of children and pets.*

FDA Label Image

Fig1 (Fig1)

An instructional diagram showing a stepwise schedule for using Habitrol Nicotine Polacrilex Lozenge Mint. It details Step 1 (1 lozenge every 1 to 2 hours at the beginning of week 1, quit date), Step 2 (1 lozenge every 2 to 4 hours at beginning of week 7), and Step 3 (1 lozenge every 4 to 8 hours at beginning of week 10), concluding with the ex-smoker stage 12 weeks after the quit date. Reminders are indicated to be placed on a calendar.*

FDA Label Image

Pic1 (Pic1)

An instructional wallet card listing phone numbers for quitting help, including contact information for the American Lung Association, American Cancer Society, American Heart Association, and a quitting buddy or friend who has quit.*

FDA Label Image

Pic2 (Pic2)

An illustrated wallet card titled 'My most important reasons to quit smoking are:' followed by five blank lines for the user to write their personal reasons. The card is designed as a motivational tool to support smoking cessation efforts.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.